Literature DB >> 8995070

Acute biliary pancreatitis: diagnosis and management.

C L Liu1, C M Lo, S T Fan.   

Abstract

Acute biliary pancreatitis is a serious complication of biliary calculous disease and is associated with significant morbidity and mortality. The role of endoscopic retrograde cholangiopancreatography (ERCP) in the management of acute biliary pancreatitis has been the focus of discussion in recent years. In addition, the exact role of laparoscopic cholecystectomy (LC) in the management of acute biliary pancreatitis has not yet been fully defined. In this report, we evaluated a protocol of emergency ERCP (within 24 hours) for predicted severe attacks, early ERCP (within 72 hours) for predicted mild attacks, and interval LC for management of acute biliary pancreatitis. Between January 1992 and June 1995 a total of 75 patients with acute biliary pancreatitis were managed according to the protocol. Bedside ultrasonography at admission diagnosed 94% of all 64 patients with gallbladder stones, but the sensitivity of visualizing choledocholithiasis was low (19%). Forty-five (60%) of them were predicted to have a severe attack by either Ranson or glucose/urea criteria. Emergency ERCP and endoscopic sphincterotomy (ES) for identifiable common bile duct (CBD) or ampullary stones were performed on all patients predicted to have a severe attack within 24 hours from presentation. An early endoscopic procedure was performed on all patients predicted to have a mild attack within 72 hours from presentation. ERCP was successful in 95% of all patients, and CBD stones were detected in 52 (69%) of them. ES and stone clearance were successful in all of these 52 patients. The morbidity associated with the endoscopic procedure was 3%, and there were no deaths. All except one patient survived the attack of acute pancreatitis, resulting in an overall mortality of 1%. Interval LC was performed on 46 patients with a conversion rate of 4%. The median postoperative hospital stay after LC was 2 days, and there was no major intraoperative or postoperative morbidity or mortality. Our experience suggests that the policy of emergency ERCP for patients with predicted severe disease, early ERCP for patients with predicted mild disease, and interval LC are associated with favorable outcomes in patients with acute biliary pancreatitis. Acute biliary pancreatitis can be managed safely and effectively by a combined endoscopic and laparoscopic approach.

Entities:  

Mesh:

Year:  1997        PMID: 8995070     DOI: 10.1007/s002689900207

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  23 in total

1.  Endoscopic sphincterotomy for bile duct stones in patients with intact gallbladders.

Authors:  D T Hansell; M A Millar; W R Murray; G R Gray; G Gillespie
Journal:  Br J Surg       Date:  1989-08       Impact factor: 6.939

2.  Controlled trial of urgent endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones.

Authors:  J P Neoptolemos; D L Carr-Locke; N J London; I A Bailey; D James; D P Fossard
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

3.  Gallstone pancreatitis: the timing of surgery.

Authors:  T R Kelly
Journal:  Surgery       Date:  1980-09       Impact factor: 3.982

4.  Gallstone pancreatitis: biliary tract pathology in relation to time of operation.

Authors:  H H Stone; T C Fabian; W E Dunlop
Journal:  Ann Surg       Date:  1981-09       Impact factor: 12.969

5.  The urgent diagnosis of gallstones in acute pancreatitis: a prospective study of three methods.

Authors:  J P Neoptolemos; A W Hall; D F Finlay; J M Berry; D L Carr-Locke; D P Fossard
Journal:  Br J Surg       Date:  1984-03       Impact factor: 6.939

6.  Biliary surgery in the same admission for gallstone-associated acute pancreatitis.

Authors:  D H Osborne; C W Imrie; D C Carter
Journal:  Br J Surg       Date:  1981-11       Impact factor: 6.939

7.  Endoscopic sphincterotomy for biliary pancreatitis: an alternative to cholecystectomy in high-risk patients.

Authors:  J H Siegel; A Veerappan; S A Cohen; F E Kasmin
Journal:  Gastrointest Endosc       Date:  1994 Sep-Oct       Impact factor: 9.427

8.  Biochemical prediction of gallstones in acute pancreatitis: a prospective study of three systems.

Authors:  B R Davidson; J P Neoptolemos; T Leese; D L Carr-Locke
Journal:  Br J Surg       Date:  1988-03       Impact factor: 6.939

9.  Influence of age on the mortality from acute pancreatitis.

Authors:  S T Fan; T K Choi; C S Lai; J Wong
Journal:  Br J Surg       Date:  1988-05       Impact factor: 6.939

10.  Timing of laparoscopic surgery in gallstone pancreatitis.

Authors:  E Tang; S C Stain; G Tang; E Froes; T V Berne
Journal:  Arch Surg       Date:  1995-05
View more
  4 in total

1.  Practical recommendations for the prediction and management of common bile duct stones in patients with gallstones.

Authors:  N A Kama; M Atli; M Doganay; M Kologlu; E Reis; M Dolapci
Journal:  Surg Endosc       Date:  2001-06-12       Impact factor: 4.584

2.  Comparative Analysis of Early Clinical Features and Complications of Different Types of Acute Pancreatitis.

Authors:  Hongsheng Wu; Keqiang Ma; Biling Liao; Tengfei Ji; Shengmin Zhang; Tiansheng Cao
Journal:  Oxid Med Cell Longev       Date:  2022-06-25       Impact factor: 7.310

3.  Acute biliary pancreatitis: an experience in a tertiary level hospital of Nepal.

Authors:  Sujan Manandhar; Smith Giri; Prakash Poudel; Ramesh Singh Bhandari; Paleswan Joshi Lakhey; Pradeep Vaidya
Journal:  Indian J Surg       Date:  2012-06-08       Impact factor: 0.656

4.  Mild acute biliary pancreatitis vs cholelithiasis: are there differences in the rate of choledocholithiasis?

Authors:  Rosa Bertolín-Bernades; Luis Sabater-Ortí; Julio Calvete-Chornet; Bruno Camps-Vilata; Norberto Cassinello-Fernández; Miguel Oviedo-Bravo; Purificación Ivorra-García Monco; Raúl Cánovas-de Lucas; Salvador Lledó-Matoses
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.